Search Results for: Beyond the PBM A New
Articles
Beyond the PBM: A New Order for Healthcare Delivery June 6, 2018
The ongoing migration of healthcare currency, from volume to value, is reshaping the healthcare ecosystem. A recent spate of vertical integration, the arrival of new players and partnerships, and the reinvention of the PBMs, continue to disrupt and transform the healthcare value chain.
Hemispherx Biopharma Receives New Composition of Matter Patent October 5, 2015
Hemispherx Biopharma, Inc. recently announced it received formal notice on September 21, 2015, that the European Patent Office's Examining Division...EXECUTIVE INTERVIEW - Petros Pharmaceuticals & Self-Care: Expanding Access to Rx Products Through a Tech-Powered OTC Pathway March 28, 2024
Fady Boctor, President and Chief Commercial Officer at Petros Pharmaceuticals, discusses the process of taking a product from Rx-to-OTC, the benefits and challenges of the process, and the future of the marketplace.
PDC* line Pharma Opens Last Cohort of PDC-Lung-101 Clinical Trial November 5, 2021
PDC*line Pharma recently announced the last cohort of patients has been opened and the first patients were dosed, in the PDC-LUNG-101 Phase 1/2 clinical trial (NCT03970746) with PDC*lung01, the company’s therapeutic cancer….
H-CYTE Announces Publication of Positive Real-World Data Relating to the Use of Innovative Treatment to Improve Overall Lung Health June 29, 2021
H-CYTE, Inc. recently announced the publication of its clinical observational study titled, Longitudinal Assessment of FEV1 Change Following Autologous Cellular...Arcturus Therapeutics & Duke-NUS Medical School Partner to Develop a COVID-19 Vaccine March 5, 2020
Arcturus Therapeutics and Duke-NUS Medical School (Duke-NUS) recently announced their partnership to develop a Coronavirus….
PDC*line Pharma Announces First Patient Dosed With its Therapeutic Cancer Vaccine March 5, 2020
PDC*line Pharma recently announced the first patient was dosed with its innovative medicinal product candidate PDC*lung01 in a Phase 1/2 trial in….
THERAPEUTIC FOCUS - Adenosine Receptors – The Promise of A3AR Research May 4, 2015
Pnina Fishman, PhD, reports that the A3AR adenosine receptor, expressed in the lungs, liver, brain, aorta, testis, and heart, may hold promise as both a therapeutic target and as a biological predictive marker.
From Volume to Value March 21, 2015
By: Alan Shortall, Unilife Chairman & CEO As healthcare markets continue to shift to a model based on value-based...
